Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease
出版年份 2022 全文链接
标题
Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-09-12
DOI
10.3389/fphar.2022.977521
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Neuroprotective effects of catechins in an experimental Parkinson’s disease model and SK-N-AS cells: evaluation of cell viability, anti-inflammatory and anti-apoptotic effects
- (2022) Gülşen Özduran et al. NEUROLOGICAL RESEARCH
- Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson’s Disease: a Systematic Review
- (2022) Michele Goulart dos Santos et al. NEUROTOXICITY RESEARCH
- Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson’s disease
- (2022) Elodie Kip et al. AGEING RESEARCH REVIEWS
- Epigallocatechin 3-gallate: From green tea to cancer therapeutics
- (2022) Manzar Alam et al. FOOD CHEMISTRY
- Biomarker of Neuroinflammation in Parkinson’s Disease
- (2022) Tsai-Wei Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age
- (2022) Ashley Payne et al. Biomolecules
- Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
- (2022) Brent R. Stockwell CELL
- A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer’s and Parkinson’s Disease
- (2021) Jun Ho Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Oxidative stress and regulated cell death in Parkinson’s disease
- (2021) P.A. Dionísio et al. AGEING RESEARCH REVIEWS
- Epigallocatechin-3-Gallate-Loaded Liposomes Favor Anti-Inflammation of Microglia Cells and Promote Neuroprotection
- (2021) Chun-Yuan Cheng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Contribution of Microglia to Neuroinflammation in Parkinson’s Disease
- (2021) Katja Badanjak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ferroptosis in infection, inflammation, and immunity
- (2021) Xin Chen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting α‐synuclein aggregation and its role in mitochondrial dysfunction in Parkinson’s disease
- (2021) Md. Ezazul Haque et al. BRITISH JOURNAL OF PHARMACOLOGY
- Natural Phytochemicals as Novel Therapeutic Strategies to Prevent and Treat Parkinson’s Disease: Current Knowledge and Future Perspectives
- (2021) Rengasamy Balakrishnan et al. Oxidative Medicine and Cellular Longevity
- Green Tea Polyphenol Epigallocatechin-Gallate in Amyloid Aggregation and Neurodegenerative Diseases
- (2021) Luiza Fernandes et al. Frontiers in Neuroscience
- Ferroptosis as a New Mechanism in Parkinson’s Disease Therapy Using Traditional Chinese Medicine
- (2021) Lijuan Wu et al. Frontiers in Pharmacology
- Parkinson’s Disease: A Nanotheranostic Approach Targeting Alpha-Synuclein Aggregation
- (2021) Fong LaiGuan Zoey et al. Frontiers in Cell and Developmental Biology
- Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases
- (2021) Priscila Baltazar Gonçalves et al. Biomolecules
- Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis
- (2021) Laxmikant Gadhe et al. BIOPHYSICAL CHEMISTRY
- Dopamine in Parkinson's disease
- (2021) Saad Latif et al. CLINICA CHIMICA ACTA
- Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease
- (2021) Yumin Wang et al. Frontiers in Pharmacology
- Alpha-Synuclein Aggregation in Parkinson's Disease
- (2021) E. Srinivasan et al. Frontiers in Medicine
- Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease
- (2021) Chih-Jan Ko et al. Biomedicines
- Analysis of DNA methylation associates the cystine–glutamate antiporter SLC7A11 with risk of Parkinson’s disease
- (2020) Costanza L. Vallerga et al. Nature Communications
- DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase
- (2020) Ji Cao et al. Nature Communications
- Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation
- (2020) Plamena R. Angelova et al. CELL DEATH AND DIFFERENTIATION
- The impact of blue light in monolayers representing tumorigenic and nontumorigenic cell membranes containing epigallocatechin-3-gallate
- (2020) Filipa Pires et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson’s disease
- (2020) Yi Xu et al. FASEB JOURNAL
- Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease
- (2020) Etienne C. Hirsch et al. MOVEMENT DISORDERS
- Neuroinflammatory Responses and Parkinson’ Disease: Pathogenic Mechanisms and Therapeutic Targets
- (2020) Liuna Yang et al. Journal of Neuroimmune Pharmacology
- Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease
- (2020) Laura Mahoney-Sánchez et al. PROGRESS IN NEUROBIOLOGY
- Green Tea Polyphenol Microparticles Based on the Oxidative Coupling of EGCG Inhibit Amyloid Aggregation/Cytotoxicity and Serve as a Platform for Drug Delivery
- (2020) Luiza Fernandes et al. ACS Biomaterials-Science & Engineering
- Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
- (2020) Marta Pajares et al. Cells
- The Role of Oxidative Stress in Parkinson’s Disease
- (2020) Kuo-Hsuan Chang et al. Antioxidants
- Oxidative Stress in Parkinson’s Disease: Potential Benefits of Antioxidant Supplementation
- (2020) Sandro Percário et al. Oxidative Medicine and Cellular Longevity
- Use of leptin-conjugated phosphatidic acid liposomes with resveratrol and epigallocatechin gallate to protect dopaminergic neurons against apoptosis for Parkinson's disease therapy
- (2020) Yung-Chih Kuo et al. Acta Biomaterialia
- The Metabolic Underpinnings of Ferroptosis
- (2020) Jiashuo Zheng et al. Cell Metabolism
- Genetic and Environmental Factors in P arkinson's Disease Converge on Immune Function and Inflammation
- (2020) Elizabeth M. Kline et al. MOVEMENT DISORDERS
- The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review
- (2020) Shuang Zhang et al. PHYTOMEDICINE
- Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson’s Disease
- (2020) Marthinus Janse van Vuuren et al. Biomolecules
- Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models
- (2019) Hayate Javed et al. Frontiers in Pharmacology
- Significant roles of neuroinflammation in Parkinson’s disease: therapeutic targets for PD prevention
- (2019) Yujeong Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- Effect of blue light irradiation on the stability of phospholipid molecules in the presence of epigallocatechin-3-gallate
- (2019) Filipa Pires et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Evaluation of EGCG Loading Capacity in DMPC Membranes
- (2019) Filipa Pires et al. LANGMUIR
- Impaired dopamine metabolism in Parkinson’s disease pathogenesis
- (2019) Anna Masato et al. Molecular Neurodegeneration
- Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein
- (2019) Yilong Teng et al. MOLECULES
- Protective Effect of (−)Epigallocatechin-3-gallate on Rotenone-Induced Parkinsonism-like Symptoms in Rats
- (2019) Hsiang-Chien Tseng et al. NEUROTOXICITY RESEARCH
- Bioavailability enhancement of EGCG by structural modification and nano-delivery: A review
- (2019) Wenzhong Dai et al. Journal of Functional Foods
- Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives
- (2018) Jin-Sung Park et al. Current Neurology and Neuroscience Reports
- (-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease
- (2018) Tingting Zhou et al. Molecular Medicine Reports
- Epigallocatechin-3-Gallate Protects and Prevents Paraquat-Induced Oxidative Stress and Neurodegeneration in Knockdown dj-1-β Drosophila melanogaster
- (2018) Daniel A. Martinez-Perez et al. NEUROTOXICITY RESEARCH
- Polyphenols in Parkinson’s Disease: A Systematic Review of In Vivo Studies
- (2018) Małgorzata Kujawska et al. Nutrients
- Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration
- (2018) Veronica Ghiglieri et al. Frontiers in Neurology
- On the role of epigallocatechin-3-gallate in protecting phospholipid molecules against UV irradiation
- (2018) Filipa Pires et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Oxidative stress and neuroinflammation in the story of Parkinson’s disease: Could targeting these pathways write a good ending?
- (2018) Kambiz Hassanzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Bioavailability of Tea Catechins and Its Improvement
- (2018) Zhuo-Yu Cai et al. MOLECULES
- Immune system responses in Parkinson's disease: Early and dynamic
- (2018) Malú G. Tansey et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The role of dopamine in the brain - lessons learned from Parkinson's disease
- (2018) David Meder et al. NEUROIMAGE
- Suppression, disaggregation, and modulation of γ-Synuclein fibrillation pathway by green tea polyphenol EGCG
- (2018) Sneha Roy et al. PROTEIN SCIENCE
- α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease
- (2017) Sushil K Singh et al. Future Medicinal Chemistry
- Metal chelator EGCG attenuates Fe(III)-induced conformational transition of α-synuclein and protects AS-PC12 cells against Fe(III)-induced death
- (2017) Juan Zhao et al. JOURNAL OF NEUROCHEMISTRY
- Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease
- (2017) Qi Xu et al. JOURNAL OF NUTRITION
- Blood-Brain Barrier Permeability of Green Tea Catechin Metabolites and their Neuritogenic Activity in Human Neuroblastoma SH-SY5Y Cells
- (2017) Keiko Unno et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Cognitive decline in Parkinson disease
- (2017) Dag Aarsland et al. Nature Reviews Neurology
- (-)-Epigallocatechin-3-Gallate Protects SH-SY5Y Cells Against 6-OHDA-Induced Cell Death through STAT3 Activation
- (2017) Lili Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- EGCG-mediated Protection of the Membrane Disruption and Cytotoxicity Caused by the ‘Active Oligomer’ of α-Synuclein
- (2017) Jee Eun Yang et al. Scientific Reports
- Antioxidants from black and green tea: from dietary modulation of oxidative stress to pharmacological mechanisms
- (2016) Ilaria Peluso et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pre-administration of BAX-inhibiting peptides decrease the loss of the nigral dopaminergic neurons in rats
- (2016) Chi Ma et al. LIFE SCIENCES
- Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson’s Disease
- (2016) Yan Xu et al. NEUROCHEMICAL RESEARCH
- The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis
- (2016) Lauren Hirsch et al. NEUROEPIDEMIOLOGY
- Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson’s disease and its progression: Disease and staging biomarkers and new drug targets
- (2016) Carine Coneglian de Farias et al. NEUROSCIENCE LETTERS
- Nrf2–ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases
- (2016) Izaskun Buendia et al. PHARMACOLOGY & THERAPEUTICS
- Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinson’s Disease: Implications for Rehabilitation
- (2016) Davide Ferrazzoli et al. Frontiers in Behavioral Neuroscience
- Time Trends in the Incidence of Parkinson Disease
- (2016) Rodolfo Savica et al. JAMA Neurology
- Neuroprotective Properties of the Standardized Extract fromCamellia sinensis(Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson’s Disease
- (2015) Natália Bitu Pinto et al. Evidence-based Complementary and Alternative Medicine
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- EGCG Protects against 6-OHDA-Induced Neurotoxicity in a Cell Culture Model
- (2015) Dan Chen et al. Parkinsons Disease
- Neuroinflammation in Parkinson’s disease and its potential as therapeutic target
- (2015) Qinqin Wang et al. Translational Neurodegeneration
- How Epigallocatechin Gallate Can Inhibit α-Synuclein Oligomer Toxicityin Vitro
- (2014) Nikolai Lorenzen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nanoencapsulation Enhances Epigallocatechin-3-gallate Stability and Its Antiatherogenic Bioactivities in Macrophages
- (2013) Jia Zhang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Epigallocatechin gallate attenuates L-DOPA-induced apoptosis in rat PC12 cells
- (2013) Myung-Yul Lee et al. Nutrition Research and Practice
- Mitochondrial dysfunction and oxidative stress in Parkinson's disease
- (2013) Sudhakar Raja Subramaniam et al. PROGRESS IN NEUROBIOLOGY
- Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1α signaling pathway
- (2012) Qinyong Ye et al. BMC Complementary and Alternative Medicine
- Low doses of paraquat and polyphenols prolong life span and locomotor activity in knock-down parkin Drosophila melanogaster exposed to oxidative stress stimuli: Implication in autosomal recessive juvenile Parkinsonism
- (2012) Leonardo Bonilla-Ramirez et al. GENE
- AMP Kinase Activation Mitigates Dopaminergic Dysfunction and Mitochondrial Abnormalities in Drosophila Models of Parkinson's Disease
- (2012) C.-H. Ng et al. JOURNAL OF NEUROSCIENCE
- Coenzyme Q10 deficiency in patients with Parkinson's disease
- (2012) Laurie K. Mischley et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds
- (2011) Mario Caruana et al. FEBS LETTERS
- Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
- (2011) Laura A. Volpicelli-Daley et al. NEURON
- Inhibition of inducible nitric oxide synthase expression and cell death by (−)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
- (2010) Ji Seon Kim et al. JOURNAL OF CLINICAL NEUROSCIENCE
- (−)-Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, reduces dichlorodiphenyl-trichloroethane (DDT)-induced cell death in dopaminergic SHSY-5Y cells
- (2010) Kwok-Keung Tai et al. NEUROSCIENCE LETTERS
- Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies
- (2010) Ki Sung Kang et al. PLoS One
- EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
- (2010) Jan Bieschke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome-Wide Microarray Analysis of the Differential Neuroprotective Effects of Antioxidants in Neuroblastoma Cells Overexpressing the Familial Parkinson’s Disease α-Synuclein A53T Mutation
- (2009) Lei Ma et al. NEUROCHEMICAL RESEARCH
- A pro-drug of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine
- (2009) Jianfei Chao et al. NEUROSCIENCE LETTERS
- Neuroprotective effects of (−)-epigallocatechin-3-gallate (EGCG) on paraquat-induced apoptosis in PC12 cells
- (2007) R HOU et al. CELL BIOLOGY INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started